These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34894278)

  • 1. Differences in the distribution of peritoneal metastases in right- versus left-sided colon cancer on MRI.
    Engbersen MP; Nerad E; Rijsemus CJV; Buffart T; Beets-Tan RGH; Aalbers AGJ; Kok NFM; Lahaye MJ
    Abdom Radiol (NY); 2022 Feb; 47(2):530-537. PubMed ID: 34894278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population-based study on the prognostic impact of primary tumor sidedness in patients with peritoneal metastases from colon cancer.
    de Boer NL; Rovers K; Burger JWA; Madsen EVE; Brandt-Kerkhof ARM; Kok NFM; de Wilt JHW; de Reuver PH; Bos A; de Hingh IHJT; Verhoef C
    Cancer Med; 2020 Aug; 9(16):5851-5859. PubMed ID: 32614506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study.
    Kotha NV; Baumgartner JM; Veerapong J; Cloyd JM; Ahmed A; Grotz TE; Leiting JL; Fournier K; Lee AJ; Dineen SP; Dessureault S; Clarke C; Mogal H; Zaidi MY; Russell MC; Patel SH; Sussman JJ; Dhar V; Lambert LA; Hendrix RJ; Abbott DE; Pokrzywa C; Lafaro K; Lee B; Greer JB; Fackche N; Lowy AM; Kelly KJ
    Ann Surg Oncol; 2019 Jul; 26(7):2234-2240. PubMed ID: 31016486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Primary Tumor Side Matter in Patients with Metastatic Colon Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?
    Kelly KJ; Alsayadnasser M; Vaida F; Veerapong J; Baumgartner JM; Patel S; Ahmad S; Barone R; Lowy AM
    Ann Surg Oncol; 2019 May; 26(5):1421-1427. PubMed ID: 30815802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of MRI for staging peritoneal metastases in patients with colorectal cancer after neoadjuvant chemotherapy.
    Rijsemus CJV; Kok NFM; Aalbers AGJ; Buffart TE; Fijneman RJA; Snaebjornsson P; Engbersen MP; Lambregts DMJ; Beets-Tan RGH; Lahaye MJ
    Eur J Radiol; 2022 Apr; 149():110225. PubMed ID: 35255321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for appendiceal and colorectal peritoneal metastases.
    Enblad M; Graf W; Birgisson H
    Eur J Surg Oncol; 2018 Jul; 44(7):997-1005. PubMed ID: 29576463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Birgisson H; Enblad M; Artursson S; Ghanipour L; Cashin P; Graf W
    Eur J Surg Oncol; 2020 Dec; 46(12):2283-2291. PubMed ID: 32873455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seeing the whole picture: Added value of MRI for extraperitoneal findings in CRS-HIPEC candidates.
    van 't Sant I; Nerad E; Rijsemus CJV; Engbersen MP; Gispen CA; Lambregts DMJ; Beets-Tan RGH; Aalbers AGJ; Kok NFM; Lahaye MJ
    Eur J Surg Oncol; 2022 Feb; 48(2):462-469. PubMed ID: 34563410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trial.
    Engbersen MP; Rijsemus CJV; Nederend J; Aalbers AGJ; de Hingh IHJT; Retel V; Lambregts DMJ; Van der Hoeven EJRJ; Boerma D; Wiezer MJ; De Vries M; Madsen EVE; Brandt-Kerkhof ARM; Van Koeverden S; De Reuver PR; Beets-Tan RGH; Kok NFM; Lahaye MJ
    BMC Cancer; 2021 Apr; 21(1):464. PubMed ID: 33902498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of metachronous peritoneal metastases in patients with pT4a versus pT4b colon cancer: An international multicentre cohort study.
    Bastiaenen VP; Aalbers AGJ; Arjona-Sánchez A; Bellato V; van der Bilt JDW; D'Hoore AD; Espinosa-Redondo E; Klaver CEL; Nagtegaal ID; van Ramshorst B; van Santvoort HC; Sica GS; Snaebjornsson P; Wasmann KATGM; de Wilt JHW; Wolthuis AM; Tanis PJ
    Eur J Surg Oncol; 2021 Sep; 47(9):2405-2413. PubMed ID: 34030920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colic and rectal tumors with peritoneal metastases treated with cytoreductive surgery and HIPEC: One homogeneous condition or two different diseases? A systematic review and meta-analysis.
    Tonello M; Sommariva A; Pirozzolo G; Mattara G; Pilati P
    Eur J Surg Oncol; 2019 Nov; 45(11):2003-2008. PubMed ID: 31217079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yttrium-90 Hepatic Radioembolization for Advanced Chemorefractory Metastatic Colorectal Cancer: Survival Outcomes Based on Right- Versus Left-Sided Primary Tumor Location.
    Wu V; Li MD; Goodwin JS; Wehrenberg-Klee EP; Zurkiya O; Kalva SP; Ganguli S
    AJR Am J Roentgenol; 2021 Nov; 217(5):1141-1152. PubMed ID: 33594907
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of colorectal cancer patients at high risk of peritoneal metastases.
    Shariff U; Seretis C; Youssef H
    J BUON; 2015 May; 20 Suppl 1():S71-9. PubMed ID: 26051336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases.
    Dresen RC; De Vuysere S; De Keyzer F; Van Cutsem E; Prenen H; Vanslembrouck R; De Hertogh G; Wolthuis A; D'Hoore A; Vandecaveye V
    Cancer Imaging; 2019 Jan; 19(1):1. PubMed ID: 30616608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer.
    Veld JV; Wisselink DD; Amelung FJ; Consten ECJ; de Wilt JHW; de Hingh I; Bemelman WA; van Hooft JE; Tanis PJ;
    Ann Surg Oncol; 2020 Aug; 27(8):2762-2773. PubMed ID: 32170481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Sidedness Is Associated with Survival in Patients with Synchronous Colorectal Peritoneal Carcinomatosis.
    Matsuda K; Tamura K; Iwamoto H; Mizumoto Y; Mitani Y; Nakamura Y; Murakami D; Sakanaka T; Yamaue H
    Oncology; 2020; 98(4):230-236. PubMed ID: 31962336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metachronous peritoneal metastases following curative resection for colon cancer: Understanding risk factors and patterns of recurrence.
    Le VH; Thornblade L; Ituarte PHG; Lai LL; Melstrom KA
    J Surg Oncol; 2021 Feb; 123(2):622-629. PubMed ID: 33616972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent of Peritoneal Metastases on Preoperative DW-MRI is Predictive of Disease-Free and Overall Survival for CRS/HIPEC Candidates with Colorectal Cancer.
    Engbersen MP; Aalbers AGJ; Van't Sant-Jansen I; Velsing JDR; Lambregts DMJ; Beets-Tan RGH; Kok NFM; Lahaye MJ
    Ann Surg Oncol; 2020 Sep; 27(9):3516-3524. PubMed ID: 32239338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Sidedness, Recurrence, and Survival After Curative Resection of Localized Colon Cancer.
    Malakorn S; Ouchi A; Hu CY; Sandhu L; Dasari A; You YN; Kopetz ES; Ellis LM; Chang GJ
    Clin Colorectal Cancer; 2021 Mar; 20(1):e53-e60. PubMed ID: 33004292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonoperative management of the primary tumor in patients with unresectable stage IV colon cancer treated with systemic chemotherapy: Higher complication rates for left-sided colon tumors.
    Verheij FS; Yuval JB; Kok NFM; Lin ST; Qin LX; Omer DM; Thompson HM; Wei IH; Widmar M; Pappou EP; Weiser MR; Nash GM; Smith JJ; Paty PB; Beets GL; Garcia-Aguilar J
    Eur J Surg Oncol; 2024 Jan; 50(1):107294. PubMed ID: 38039906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.